Weiss Multi-Strategy Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,000	Closed	-$603K	–	576
2017 Q1	$603K	Buy	+15,000	New	+$674K	0.02%	437
2015 Q4	–	Sell	-30,000	Closed	-$1.21M	–	415
2015 Q3	$1.21M	Buy	+30,000	New	+$1.55M	0.05%	243
2015 Q1	–	Sell	-5,000	Closed	-$309K	–	479
2014 Q4	$309K	Sell	5,000 -5,000	-50%	-$247K	0.01%	362
2014 Q3	$388K	Sell	10,000 -8,800	-47%	-$312K	0.01%	455
2014 Q2	$648K	Buy	+18,800	New	+$592K	0.01%	477
2014 Q1	–	Sell	-10,000	Closed	-$398K	–	1036
2013 Q4	$398K	Hold	10,000	–	–	0.01%	687
2013 Q3	$375K	Buy	+10,000	New	+$299K	0.01%	637

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IONS Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 5,073 shares — an estimated $202K sold.

Weiss Multi-Strategy Advisers first reported a position in IONS in Q4 2013 and held it in 14 quarters. The position peaked at $1.29M in Q3 2018. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

Weiss Multi-Strategy Advisers reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 5,073 Ionis Pharmaceuticals shares in Q3 2021, an estimated $202K.
Weiss Multi-Strategy Advisers first reported a position in Ionis Pharmaceuticals in Q4 2013 and held it in 14 quarters.
Weiss Multi-Strategy Advisers's Ionis Pharmaceuticals position peaked at $1.29M in Q3 2018.
324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.